Delivery Order SPE2DB22D2206-SPE2DB25FHB34

Award Date 5/20/25
Potential Completion Date 6/11/25
Potential Value $60K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,960.42, is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside contract with a performance period through May 12, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a $59,802.10 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty medication, with a completion date of April 1, 2025. The contract has a firm fixed price pricing type and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product, with a ceiling value of $59,802.10 and a period of performance through May 9, 2025. The contract is not set aside and was awarded on April 18, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $59,802.10, is for the procurement of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialized pharmaceutical product. The contract is a firm fixed-price delivery order, with a completion date of March 20, 2025. The award was made on February 27, 2025, and there is no set-aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product, with a ceiling value of $17,940.63 and a period of performance through May 27, 2025. The contract is a firm fixed-price delivery order, which is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $23,920.84 and is for the delivery of DARZALEX FASPRO, a pharmaceutical product used for medical treatment. The contract has a firm fixed price pricing type and an ultimate completion date of April 2, 2025. This contract does not have a set-aside designation, indicating it was...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML. The contract has a firm fixed price of $11,040.84 and an ultimate completion date of December 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $95,683.36, is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a medication, to support federal medical supply requirements. The delivery order has a completion date of June 13, 2025 and uses a firm-fixed-price pricing mechanism. The contract is not set aside for any...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,881.26, is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product. The contract has an ultimate completion date of May 1, 2025. AmerisourceBergen Drug Corp is the prime contractor and there are no subcontractors mentioned. This contract is not...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML. The firm-fixed-price contract has a ceiling value of $5,980.21 and a period of performance ending on June 3, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FHB34
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product, with a ceiling value of $59,802.10. The contract has a firm-fixed price pricing type and an ultimate completion date of June 11, 2025. The contract is not set aside and was awarded on May 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 8/24/25, 1:12 AM